Legofer (Ferrous Succinate)

Quick links

Choose a section

Quick links to important sections

Advertisements

Legofer (Ferrous Succinate)

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Legofer (Ferrous Succinate)

Property Description
Active ingredient Ferrous Succinate
Form Oral Solution, Syrup (also available as Tablet)
Pharmacological class Antianemic preparation / Hematinic agent
General purpose Iron source for mineral replacement
Origin Synthetic Iron Salt

Legofer is a pharmaceutical preparation classified as a Hematinic agent and antianemic preparation, intended for systemic mineral replacement. Its sole active constituent is Ferrous Succinate, which is an iron salt designed for oral ingestion. The World Health Organization (WHO) Anatomical Therapeutic Chemical (ATC) classification system groups Ferrous Succinate under B03AA06 (Iron bivalent, oral preparations). Pharmacological studies have widely confirmed the efficacy of this iron class for restoring iron stores in the body.

This medication is fundamentally a single-ingredient product whose purpose is to provide the body with bioavailable ferrous iron. Ferrous Succinate is a specific chemical compound where iron is combined with succinic acid. This structure is clinically recognized for its role in delivering essential iron for metabolic processes.

Legofer is typically supplied for the patient as an Oral Solution or Syrup, making it a liquid preparation taken by the oral administration route. This format is specifically helpful for patient groups such as children and those with swallowing difficulties. The primary therapeutic purpose is to act as a targeted source of an essential mineral to correct systemic deficiencies, a common scenario for pregnant women or individuals with increased iron loss. Iron salts, such as Ferrous Succinate, are recognized as the cornerstone of therapy for iron deficiency. By ensuring the availability of this absorbed iron, this formulation supports the crucial process of hemoglobin synthesis within red blood cells, enabling efficient oxygen transport.

Regulatory References

  1. NIH MedlinePlus Overview
Advertisements

What side effects are possible with Legofer (Ferrous Succinate)?

Possible Side Effects and Safety Information: Legofer (Ferrous Succinate)

Legofer (ferrous succinate) is an oral iron supplement used to treat and prevent iron-deficiency anemia. While generally well-tolerated when used as directed, patients should be aware of potential side effects, primarily related to the gastrointestinal system.


Common Side Effects

The most frequently reported side effects are mild and transient. These are often mitigated by taking the supplement with food or adjusting the dose as advised by a healthcare provider.

Side Effect Description
Gastrointestinal Distress Nausea, vomiting, abdominal pain, or cramping.
Constipation or Diarrhea Changes in bowel habits.
Darkened Stools Stools may appear black or dark green; this is a harmless and expected result of unabsorbed iron.

Less Common and Serious Side Effects

Allergic reactions are rare but require immediate medical attention. Symptoms may include rash, itching, swelling (especially of the face, tongue, or throat), severe dizziness, or trouble breathing.

An overdose of iron is a medical emergency, particularly in children, and can lead to severe gastrointestinal distress, metabolic acidosis, shock, and potentially death. Legofer products should be stored securely out of the reach of children.


Safety Precautions and Drug Interactions

Iron supplements can interfere with the absorption of certain other medications, including tetracycline antibiotics, fluoroquinolones, and drugs used to treat osteoporosis (bisphosphonates) or hypothyroidism (levothyroxine). To minimize these interactions, iron supplements should typically be taken at least two to four hours apart from these other medications. Patients with pre-existing conditions like hemochromatosis (a condition causing iron overload) or certain types of anemia not caused by iron deficiency (e.g., hemolytic anemia) should avoid ferrous succinate unless specifically advised otherwise by a physician.

Advertisements

Overdose and Emergency Response

Acute overdose of Legofer (Ferrous Succinate), an iron salt, typically presents in progressive stages. The initial phase is marked by severe gastrointestinal toxicity, including vomiting, diarrhea (potentially bloody), and abdominal pain. Systemic effects can rapidly follow, involving tachycardia, hypotension, and signs of CNS depression that may range from lethargy to coma. Severe, life-threatening outcomes documented in regulatory files include shock, metabolic acidosis, hepatic necrosis, and renal failure. Later effects in survivors may involve gastrointestinal obstruction or scarring.

Regulatory documents mandate that immediate emergency medical attention must be sought for any suspected overdose. This action is critical, as accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age.

Management for systemic toxicity includes continuous hospital monitoring of vital signs and laboratory values, such as serum iron levels, to determine severity. For severe cases, the official label specifies the use of the chelating agent Deferoxamine (Desferrioxamine) as an antidote, along with supportive procedures like whole-bowel irrigation or IV fluid resuscitation.

Advertisements

Therapeutic Uses of Legofer (Ferrous Succinate)

Legofer (Ferrous Succinate) is applied in addressing the symptomatic burden associated with iron deficiency. This application is relevant in clinical settings marked by temporary physiological imbalance. Its purpose is to function as an essential mineral replacement, contributing to the easing of the overall symptom load.

The primary therapeutic focus is the management of iron deficiency anemia (IDA) and the supportive addressing of iron-deficient states. The medication is commonly used across conditions presenting with acute episodes of deficiency, such as those caused by chronic blood loss, malabsorption, or periods of heightened physiological demand.

Iron supply is an essential component for functional stability. This medication is relevant for managing symptom clusters that interfere with daily functioning, including chronic fatigue, listlessness, physical weakness, and associated cardiopulmonary stress signs. It contributes to easing the overall symptom load and may help improve day-to-day comfort during symptomatic periods. The approach is aimed at supporting the restoration of the body’s iron stores and hemoglobin levels, which may assist with easing symptoms.

Quick Fact: Relief for Systemic Fatigue Ferrous Succinate supports the patient during difficult episodes by easing the distress caused by chronic exhaustion and reduced physical stamina associated with low iron levels.

Regulatory References

  1. NIH MedlinePlus Medical Encyclopedia
Advertisements

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Legofer (Ferrous Succinate)

This section outlines the population eligibility rules for Legofer (Ferrous Succinate) as defined by official regulatory documentation for oral bivalent iron salts.


Contraindicated Populations

Use is strictly contraindicated for individuals with confirmed iron overload syndromes, including hemochromatosis or hemosiderosis, as the medicine would exacerbate the condition. Patients with anemia not caused by iron deficiency, such as hemolytic anemia, must not use this product.

Contraindication extends to patients with active, severe gastrointestinal conditions, including an active peptic ulcer, ulcerative colitis, or regional enteritis (Crohn's disease). It is also prohibited for patients currently receiving parenteral (injectable) iron preparations or those who have known hypersensitivity to ferrous succinate.


Age-Group and Physiological Status

  • Adults: Standard population for use.
  • Pregnancy and Lactation: Use is generally permitted and recommended for confirmed iron deficiency, with no contraindications established.
  • Pediatric Use: The liquid Oral Solution/Syrup form is established for use in infants and young children. However, tablet forms are generally not recommended for children under 12 years of age.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Ferrous succinate can interact with numerous medications, affecting the absorption and efficacy of either the iron supplement or the other drugs. It is crucial to inform a healthcare provider of all prescription and non-prescription medicines, vitamins, and supplements being taken.

Medications that Decrease Ferrous Succinate Absorption

Certain medicines can reduce the amount of iron the body absorbs, potentially making the treatment less effective. To minimize this effect, these drugs should generally be taken at least two hours before or four hours after ferrous succinate:

  • Antacids and Acid Reducers: Calcium carbonate, proton pump inhibitors (e.g., omeprazole), and H2 blockers (e.g., cimetidine, famotidine) decrease gastric acidity, which is necessary for optimal iron absorption.
  • Certain Antibiotics: Tetracyclines (e.g., doxycycline) and quinolones (e.g., ciprofloxacin) form complexes with iron.
  • Other Agents: Cholestyramine, a medicine for high cholesterol, and some phosphate binders.

Medications Whose Absorption is Decreased by Ferrous Succinate

Ferrous succinate can bind to certain medicines in the gastrointestinal tract, reducing the absorption and effectiveness of those drugs. A separation of doses by at least two to four hours is often required for:

  • Levothyroxine (for underactive thyroid)
  • Levodopa/Carbidopa (for Parkinson's disease)
  • Bisphosphonates (for osteoporosis)
  • Penicillamine (for rheumatoid arthritis and Wilson's disease)

Food and Supplements

Certain foods and dietary supplements can also inhibit iron absorption. The following should be avoided within two hours of taking ferrous succinate: milk, dairy products, eggs, tea, coffee, and high-fiber foods. Supplements containing calcium, zinc, and magnesium should also be separated by a few hours.

Advertisements

Mechanism of Action

Iron Dissociation and Gastrointestinal Uptake

Legofer (Ferrous Succinate) provides the substrate, ferrous succinate, which undergoes rapid dissociation in the stomach's acidic environment to release the active ferrous ion ( Fe^2+). This Fe^2+ is the prerequisite form of iron that is absorbed from the intestinal lumen into the enterocytes primarily via the Divalent Metal Transporter 1 (DMT1). This initial absorption introduces the core element into the systemic circulation.


Systemic Transport and Heme Pathway Engagement

Once absorbed, the Fe^2+ is either stored intracellularly as ferritin or exported into the bloodstream via the efflux transporter ferroportin. Systemically, Fe^2+ is oxidized to the ferric form ( Fe^3+) and bound to the carrier protein transferrin. This transferrin-bound iron is directed primarily to the bone marrow, where it is sequestered by erythroid precursor cells. Here, the iron is integrated into the porphyrin ring structure, serving as the essential substrate for heme production and subsequent hemoglobin synthesis. This process constitutes the core mechanism of action at the cellular and physiological level.

Advertisements

Dosage and Administration Information

How to Use Legofer (Ferrous Succinate)

Ferrous succinate is an oral preparation of bivalent iron, and its use is strictly guided by the official instructions for oral iron salts as defined by regulatory agencies. The primary objective of the administration protocol is to ensure iron absorption while managing potential gastrointestinal effects.

The medication is available as an oral solution/syrup or in tablet form. To maximize the absorption of iron, it is generally intended to be taken on an empty stomach (e.g., 30 minutes before or two hours after a meal). However, if gastrointestinal discomfort occurs, the drug may be taken with or immediately after food as a modification to improve tolerability.

Dosing and Administration Patterns

Usage Context Standard Official Regimen (Elemental Iron)
Adult Treatment Dose 65 mg to 200 mg daily, administered once or in divided doses.
Pediatric Treatment Dose Calculated on a weight basis, often 3 mg to 6 mg per kg per day, typically given in divided doses.

The standard frequency pattern involves administration once daily; however, alternate-day dosing is recognized as an effective approach to limit side effects. For liquid forms, the dose must be accurately measured and diluted with water or fruit juice before consumption to minimize temporary tooth discoloration. Tablets must be swallowed whole without chewing or crushing. The treatment course is officially structured to last several months, typically continuing for up to three to six months total, including a minimum of three months after the normalization of blood hemoglobin levels to ensure the repletion of body iron stores.

Advertisements

Recent Clinical Evidence

Recent Clinical Evidence

Ferrous succinate is an iron replacement product used in the prevention and treatment of iron deficiency anemia (IDA). Clinical research consistently evaluates the effectiveness and tolerability of oral iron supplements, including ferrous succinate, particularly across different patient populations.


Efficacy and Absorption Studies

Studies focused on the treatment of IDA often assess primary outcomes such as the rise in hemoglobin (Hb) and the replenishment of serum ferritin levels over a course of treatment. Research suggests that the efficacy of oral iron preparations may depend on factors including the formulation, dosage, and individual patient tolerance.

  • Hemoglobin Response: Clinical trials have examined the rate and degree of increase in hemoglobin concentration in patients diagnosed with IDA who received ferrous succinate. Findings generally align with other ferrous salt forms in achieving clinically relevant increases in iron status markers.
  • Comparative Trials: Studies comparing different iron formulations have explored whether ferrous succinate demonstrates different rates of gastrointestinal side effects or distinct absorption profiles compared to alternatives like ferrous sulfate or ferrous fumarate.

Tolerability and Safety Profile

Research on ferrous succinate emphasizes its tolerability, which is a key consideration for patient adherence to treatment. Gastrointestinal upset—such as nausea, constipation, or diarrhea—is a common reported adverse event across all oral iron treatments.

Key Safety Research Areas:

Research Focus Study Goal
Adherence Rates Assessing whether the formulation leads to better patient compliance compared to other salts.
Adverse Events Documenting the frequency and severity of reported side effects, primarily gastrointestinal, in treated populations.

Overall evidence confirms ferrous succinate as a clinically appropriate and established option for managing iron deficiency, with ongoing research focusing on optimizing patient outcomes and minimizing common side effects.

Key Studies & References Diagnosis and management of iron deficiency anaemia: a clinical review

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Legofer (Ferrous Succinate) (FAQ)

Q: Is Legofer the same thing as a regular iron pill?

A: Legofer contains the active ingredient ferrous succinate, which is officially classified as a type of oral iron salt. This means it belongs to the same general category as other common iron pills, such as those containing ferrous sulfate or ferrous fumarate, and functions as an oral source of iron.

Q: What should I expect Legofer to do for me?

A: The officially recommended purpose of this medication, according to regulatory documents, is the prevention and treatment of iron deficiency anemia. It works by providing the essential iron your body needs to correct the deficiency.

Q: What are the most common reasons a doctor prescribes Legofer?

A: It is officially indicated for treating conditions that result from a low level of iron in the body, most commonly iron deficiency anemia. This occurs when the body does not have enough iron to create the necessary amount of hemoglobin.

Q: Can Legofer be taken by teenagers who have low iron?

A: Official clinical guidelines often outline dosing schedules for adolescents and children. Use in these groups is typically determined by a healthcare professional and calculated on a weight-adjusted basis.

Q: Are there any long-term effects of taking Legofer?

A: Regulatory documents define the necessary treatment course, which is often structured for several months. Official information advises that prolonged use beyond medical necessity carries a risk of iron accumulation or iron overload in the body.

Q: Is Legofer safe to take if I am already taking thyroid medication?

A: Iron supplements may decrease the absorption of certain thyroid medications, such as levothyroxine, which could make the thyroid medication less effective. Official product information describes that these medications may need to be spaced apart during administration to help minimize interaction.

Q: Can Legofer change the color of my stools?

A: Yes, a common and expected effect of taking oral iron is the stools becoming darker or black in color. Regulatory documents confirm this is due to unabsorbed iron.

Q: Does Legofer help with feeling tired all the time?

A: The medicine is prescribed to treat iron deficiency anemia. This condition is often characterized by symptoms such as fatigue, weakness, and persistent tiredness, and treating the deficiency may be associated with the relief of these symptoms.

Q: Are there certain foods or drinks I should absolutely avoid when taking Legofer?

A: Yes. To maximize iron absorption, it is generally recommended to avoid taking the medication at the same time as dairy products, coffee, tea, and calcium-containing supplements. These items are known to reduce the amount of iron the body can absorb.

Q: Can Legofer be taken at the same time as my vitamin D supplement?

A: Official warnings often advise spacing the dose of iron from other mineral supplements like calcium or zinc. This precaution is advised because the simultaneous intake of multiple minerals may interfere with iron absorption.

Q: How is Legofer different from just eating iron-rich foods?

A: Legofer is a therapeutic medicine prescribed to treat a confirmed state of iron deficiency anemia. This is a clinical condition that cannot typically be corrected solely by increasing the intake of iron-rich foods.

Q: What is the iron content in Legofer compared to my daily recommended intake?

A: The official product information specifies the amount of elemental iron contained in each dose. This elemental iron content is typically a therapeutic dose, which is much higher than the general Recommended Daily Allowance (RDA) because it is intended to correct a deficiency.

Q: If I feel better, do I still need to keep taking Legofer?

A: The recommended duration of treatment is structured to ensure the repletion of body iron stores, not just to relieve symptoms. Treatment often continues for three to six months after blood hemoglobin levels have returned to normal to fully rebuild these reserves.

Q: Does taking Legofer affect my ability to drive or operate machinery?

A: Official product information typically states that the medication is not known to impair the ability to drive or operate machinery. You should only be cautious if you experience known side effects that might affect alertness.

Q: Can Legofer be purchased over the counter, or is it prescription only?

A: The regulatory status of the product, whether it requires a prescription or is available over-the-counter, is determined by the strength and specific formulation authorized in your particular region.

Q: What is the ingredient Ferrous Succinate exactly?

A: Ferrous succinate is chemically defined by authoritative sources as an iron (II) salt. This chemical structure allows it to be used as an effective oral source of iron that the body can absorb.

Q: Why do some people take Legofer for pregnancy-related low iron?

A: Official health guidance often recommends iron supplementation during pregnancy. This is to prevent iron deficiency, which is common during gestation, as maternal anemia can pose risks to the developing infant.

Q: Does Legofer interact with common pain relievers like ibuprofen?

A: Some regulatory and medical sources advise caution when taking oral iron supplements with non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen. Both can potentially increase the risk of gastrointestinal irritation.

Q: Is Legofer appropriate for older adults?

A: Unless a specific contraindication or existing medical condition is present, the medication is generally considered suitable for use across the adult population. The application is based on individual clinical need.

Q: Can I take Legofer if I have a history of stomach ulcers?

A: A history of a stomach ulcer or other serious gastrointestinal issues is typically listed in official product information as a precaution or contraindication for the use of oral iron supplements.

Q: What health conditions might prevent someone from taking Legofer?

A: Official warnings specify that individuals with conditions that cause iron overload (such as hemochromatosis) are typically contraindicated from taking iron supplements. Certain serious gastrointestinal diseases are also listed.

Q: Is Legofer safe for people with kidney issues?

A: Regulatory information addresses the use of iron to treat anemia associated with conditions such as chronic kidney disease in certain patient contexts. Use is determined based on individual clinical need.

Q: Do I need to get blood tests while taking Legofer?

A: The official duration of treatment is linked to the normalization of blood hemoglobin levels and the repletion of iron stores. Monitoring of these levels may be needed to confirm the treatment is proceeding as intended.

Q: Does alcohol consumption affect Legofer?

A: Official documentation may advise caution regarding alcohol consumption. Both iron supplements and alcohol can potentially increase the risk of gastrointestinal upset.

Q: What is the official recommended purpose of Legofer according to regulators?

A: The medicine is officially prescribed for the prevention and treatment of iron deficiency anemia, a condition defined by low levels of red blood cells caused by insufficient iron.

Q: Are there any specific warnings about Legofer and children?

A: Regulatory bodies issue a prominent warning about the risk of accidental overdose of iron-containing products in young children. Iron poisoning can be severe and is a key concern highlighted in official safety documents.

Q: Is Legofer a 'blood builder'?

A: This term is common in public conversation, but the scientific function of the medication is to provide iron, an essential element the body requires to synthesize hemoglobin. Hemoglobin is the oxygen-carrying component of red blood cells.

Q: What is known about Legofer's use in women who have heavy periods?

A: The drug is used to treat iron deficiency anemia, which commonly results from chronic blood loss. Conditions like heavy menstrual periods are a frequent cause of this type of blood loss and subsequent anemia.

Q: Can I take Legofer if I have a diagnosis of hemochromatosis?

A: Conditions that cause iron overload in the body, such as hemochromatosis, are typically listed as a contraindication for taking iron supplements, as additional iron can worsen the condition.

Q: Are there different strengths of Legofer tablets?

A: Yes, official product labeling indicates that the medication is available in different strengths (dosages) of elemental iron. The prescribed strength is based on the individual's needs to treat the deficiency.

Q: Does taking Legofer require any changes to my diet?

A: Official guidance recommends avoiding foods that are known to block iron absorption (like dairy and coffee) when taking the dose. This is described as a strategy to help optimize absorption.

Q: Is Legofer considered a supplement or a medicine?

A: It is officially classified by regulatory bodies as a medicine (drug) used to treat iron deficiency anemia. This classification means its use is strictly regulated and requires professional medical guidance.

Q: What are the rare, but serious, side effects listed for Legofer?

A: Regulatory documents list rare but serious risks associated with oral iron. These include the danger of acute iron poisoning (overdose) and the potential for severe allergic reactions.

Q: Can Legofer be taken with milk?

A: Milk and other dairy products are known to contain calcium, which may reduce the amount of iron the body can absorb from the medication. It is generally advised to take the dose separately from milk.

Advertisements

How should Legofer (Ferrous Succinate) be stored and disposed of?

How to Store and Dispose of Legofer (Ferrous Succinate)?

The storage and disposal of Ferrous Succinate are governed by regulatory requirements to ensure product stability and prevent accidental poisoning.

Official Storage Requirements

Condition Regulatory Mandate
Temperature Store at or below 25°C (77°F), in a cool place.
Protection Keep the container tightly closed and protect the product from light and moisture.
Container Store the medicine in its original container.
Child Safety The medicine must be kept strictly out of the reach and sight of children due to the risk of fatal overdose.

Disposal Instructions

Unused or expired Ferrous Succinate should be discarded by utilizing a community drug take-back program. If no program is available, the medicine must be removed from the container, mixed with an undesirable substance (e.g., coffee grounds), sealed in a bag, and then placed in the household trash. The medicine should not be flushed down a sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Legofer (Ferrous Succinate) found in:

A-Z Index: